Maze Therapeutics appoints Misbah Tahir as CFO, effective Sep 2, 2025

Maze Therapeutics, Inc.

Misbah Tahir appointed CFO, previously CFO of IGM Biosciences (Jan 2019–Aug 2025).
Annual base salary of $500,000, discretionary bonus up to 40% of base salary.
One-time sign-on bonus of $50,000 (clawback if service <1 year) and option for 325,000 shares.
Option vests 25% on first anniversary, then 1/48th monthly; severance includes 9 months base salary plus benefits.
Enhanced severance on termination without cause or for good reason within 3 months before/12 months after change in control.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.